Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 12Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 4603Pancreatic Neoplasms 2843Carcinoma, Hepatocellular 2479Stomach Neoplasms 2329Colonic Neoplasms 1790Rectal Neoplasms 1719Esophageal Neoplasms 1376Liver Neoplasms 920Neoplasms 915Breast Neoplasms 839Neoplasm Metastasis 764Carcinoma, Non-Small-Cell Lung 705Cholangiocarcinoma 587Lung Neoplasms 556Ovarian Neoplasms 535Esophageal Squamous Cell Carcinoma 513Gastrointestinal Neoplasms 495Melanoma 381Prostatic Neoplasms 373Biliary Tract Neoplasms 373Head and Neck Neoplasms 303Uterine Cervical Neoplasms 288Carcinoma, Renal Cell 284Adenocarcinoma Of Esophagus 273Squamous Cell Carcinoma of Head and Neck 264Sarcoma 263Gastrointestinal Stromal Tumors 252Endometrial Neoplasms 235Urinary Bladder Neoplasms 226Gallbladder Neoplasms 225

Interventions

Liver Transplantation 1Erlotinib Hydrochloride 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cholangitis, Sclerosing × Gastrointestinal × Clear all
NCT00955149 2014-01-10

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

Mayo Clinic

Phase 1 Completed
6 enrolled
Gastrointestinal

Cholangitis, Sclerosing, Cholangiocarcinoma

NCT01549795 2012-07-18

Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy

Azienda Ospedaliera di Padova

Phase NA Unknown
33 enrolled
Gastrointestinal

Cholangitis, Sclerosing, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡